A Pharmacist-Led Process to Monitor Discrepant Urine Drug Screen Results.
- Published in:
- Federal Practitioner, 2024, v. 41, n. 3, p. 93, doi. 10.12788/fp.0458
- By:
- Publication type:
- Article
Works matching IS 10784497 AND DT 2024 AND VI 41 AND IP 3
Results: 6
1
2
Outcomes and Barriers Associated with Telehealth-Based Hepatitis C Treatment During Early Phases of the COVID-19 Pandemic.
- Published in:
- Federal Practitioner, 2024, v. 41, n. 3, p. 88, doi. 10.12788/fp.0460
- By:
- Publication type:
- Article
3
Medication-Nonadherent Hypothyroidism Requiring Frequent Primary Care Visits to Achieve Euthyroidism.
- Published in:
- Federal Practitioner, 2024, v. 41, n. 3, p. 84, doi. 10.12788/fp.0461
- By:
- Publication type:
- Article
4
Clinical Implications of a Formulary Conversion From Budesonide/formoterol to Fluticasone/salmeterol at a VA Medical Center.
- Published in:
- Federal Practitioner, 2024, v. 41, n. 3, p. 80, doi. 10.12788/fp.0459
- By:
- Publication type:
- Article
5
Diabetes Basic Training Program: Empowering Veterans for Wellness.
- Published in:
- Federal Practitioner, 2024, v. 41, n. 3, p. 74, doi. 10.12788/fp.0450
- By:
- Publication type:
- Article
6
Fighting to Serve: Women in Military Medicine: Let the generations know that women in uniform also guaranteed their freedom.
- Published in:
- Federal Practitioner, 2024, v. 41, n. 3, p. 72, doi. 10.12788/fp.0465
- By:
- Publication type:
- Article